Researchers at the Universities of York and Leiden have pioneered a technique which uses florescent imaging to track the actions of key enzymes in cancer, genetic disorders and kidney disease.
Scientists hope this new development will aid drug design for new anti-cancer, inflammation and kidney disease treatments.
It will also provide diagnostic tools for disease identification and allow medical professionals to measure the effectiveness of drug treatment regimes in an easy laboratory manner.
Studying heparanase – a key enzyme in the development and metastasis of human cancers – scientists unveiled new fluorescent imaging agents that detect enzyme activity in healthy and diseased tissues.
The research, published this week in Nature Chemical Biology, builds upon previous work revealing heparanase’s three-dimensional structure.
Heparanase is a long-studied protein in human tissues involved in breaking down the complex sugars of the “extracellular matrix” – the material surrounding cells that provides structure and stability.
Heparanase dysfunction is linked to the spread of cancers both through the breakdown of this matrix and via the subsequent release of “growth factors” – chemicals that promote tumour development.
Through its remodelling of the matrix, heparanase is also a key player in inflammation and kidney disease. It is therefore a major drug, and diagnostic probe, target.
Early disease identification
Gideon Davies, Professor of Structural Enzymology and Carbohydrate Chemistry at the University of York, said: “Heparanase is a key human enzyme. Its dysregulation is involved in inherited genetic disorders, and it is also a major anti-cancer target and increasingly implicated in kidney disease.
“Our work allows us to probe the activity of heparanase in human samples – allowing early disease identification and a direct measure of the success of drugs in humans.
“This work is a great example of the power of EU collaboration and science funding from the European Research Council.”
Hermen Overkleeft, Professor of Bio-Organic Synthesis at Leiden University, added: “This work reveals the power of activity-based protein profiling: the probe described here at once enables screening for heparanase inhibitors from large compound collections and is a lead compound for drug development in its own right.
“While the road to heparanase-targeting clinical drugs is long and fraught with risks, with this work we believe to have taken a major step in realising the therapeutic potential of this promising clinical target.”
The Latest on: Florescent imaging
- Gel Imaging Documentation Market – Industry Outlook, Size, Share, Growth Prospects, Key Opportunities, Trends and Forecasts 2016-2026 on April 18, 2019 at 6:41 am
... of different component such as an imaging system, a computer, a light source, analysis software and a printer. For instance, G:BOX F3 is an entry level gel documentation system manufactured by ... […]
- Nanoscale magnetic imaging of ferritin in a single cell on April 18, 2019 at 6:34 am
However, nanoscale imaging of intracellular proteins has ... The scientists measured fluorescence decay at a fixed free evolution time of 50 microseconds (τ = 50 μs) to reveal the degree of ... […]
- Cell-penetrating peptide sequence and modification dependent uptake and subcellular distribution of green florescent protein in different cell lines on April 18, 2019 at 2:13 am
Here we use green fluorescent protein (GFP ... h under cell culture conditions then washed with heparin sulphate solution and culture media before imaging. Heparin sulphate is highly negatively ... […]
- Fluorescent nanoparticles drive a bright start(up) on April 18, 2019 at 1:38 am
Our first thought was to use CPNs for tumour imaging – you could do multi-modal imaging with MRI alongside these fluorescent markers. However, when we presented the idea to venture capitalists (VCs), ... […]
- Global Near Infrared Imaging Market Will Reach USD 1,094 Million By 2025: Zion Market Research on April 17, 2019 at 6:26 am
New York, NY, April 17, 2019 (GLOBE NEWSWIRE) -- Zion Market Research has published a new report titled “Near Infrared Imaging Market by Product (Reagents and NIR Bioluminescence & Fluorescence ... […]
via Google News and Bing News